Exploring Clinical Predictors of COPD Exacerbation in a Community Cohort
Not Applicable
Not yet recruiting
- Conditions
- COPD Exacerbation
- Interventions
- Other: Experimental
- Registration Number
- NCT05762861
- Lead Sponsor
- University of Minho
- Brief Summary
The aim of our study is to assess the feasibility and benefits of the implementation of an interactive telemonitoring system for earlier detection of COPD exacerbations in a community cohort preventing further deterioration requiring hospital admissions.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
- Diagnosis of COPD
- Aged 40 years or above
- Must be enrolled in health centres from Braga
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Home telemonitoring Experimental Group 2: To keep follow-up in their usual family practice/ pulmonology consultations and associate an interactive home telemonitoring system managed by the researchers.
- Primary Outcome Measures
Name Time Method Impact of the programme - satisfaction level 18 months Measurement tool - questionnaire
Number of COPD exacerbation with hospital admission 18 months Quality of Life using St. George's Respiratory Questionnaire 18 months Scores range from 0 (no effect on quality of life) to a maximum score of 100 (maximum perceived distress). A higher score means a poorer quality of life
Impact of the programme - rate of compliance 18 months Measurement tool - questionnaire
Impact of the programme - % of retention of participating patients 18 months Measurement tool - questionnaire
Impact of COPD on patient's life using COPD Assessment Test (CAT) 18 months Range of CAT scores from 0-40. Higher scores denote a more severe impact of COPD on a patient's life.
Number of COPD exacerbation managed at home 18 months
- Secondary Outcome Measures
Name Time Method Dyspnoea level (mMRC) 18 months Pulmonary function (FEV1 and FEV1/ FVC ratio after BD) 18 months Changes in GOLD classification 18 months